论文部分内容阅读
1994年7~8月,我们对11例经住院治疗并使用各种纠正心衰药物效果欠佳的顽固性心衰患者,改用氨力农(Amrinone,AMr)治疗后取得较好效果,现分析报告如下。一、观察对象:本组11例均为在本院内科住院治疗患者,其中男性7例,女性4例。年龄36~72岁,平均52.6岁。按照国内拟定疾病统一标准进行病因学分类:肺心病(Ⅱ)呼衰6例,扩张性心肌病2例,冠心病3例(合并左心乳头肌功能不全)。11例病人全部有心力衰竭:(1)使用纽约心脏病协会(NYHA)标准均在Ⅲ级以上。部分病人合并有心律
From July to August 1994, 11 patients with refractory heart failure who were hospitalized and used various kinds of drugs to correct heart failure were treated with Amrinone (AMr) and achieved good results The analysis report is as follows. First, the observation object: The group of 11 patients were hospitalized in our hospital patients, including 7 males and 4 females. Age 36 to 72 years old, average 52.6 years old. In accordance with the national standards for the development of a unified etiology of disease classification: pulmonary heart disease (Ⅱ) respiratory failure in 6 cases, 2 cases of dilated cardiomyopathy, coronary heart disease in 3 cases (with left heart papillary muscle dysfunction). All 11 patients had heart failure: (1) New York Heart Association (NYHA) standards were above Grade III. Some patients with heart rhythm